Skip to main content
Back to Bills
FederalDid not become law (session ended)44th Parliament, 1st Session

Bill S-232 explained in plain English

An Act respecting the development of a national strategy for the decriminalization of illegal substances, to amend the Controlled Drugs and Substances Act and to make consequential amendments to other Acts

Federal Parliament bill summary, status, timeline, sponsor, votes, and official sources.

At a glance

Jurisdiction
Federal Parliament
Legislature / Parliament
Parliament of Canada
Session
44th Parliament, 1st Session
Bill number
Bill S-232
Full title
An Act respecting the development of a national strategy for the decriminalization of illegal substances, to amend the Controlled Drugs and Substances Act and to make consequential amendments to other Acts
Current status
Did not become law (session ended)
Latest event
At consideration in committee in the Senate
Last updated
Apr 11, 2024

Official Parliament of Canada snapshot for 44th Parliament, 1st Session. MP vote breakdowns appear when the House of Commons publishes a recorded division export for that bill. Senate and House stage details include official debate/sitting links when LEGISinfo publishes them.

Chamber
Parliament of Canada
Current Stage
At consideration in committee in the Senate
Latest Activity
Apr 11, 2024
Plain-language explanation
In plain English (our explanation)

Our plain-language take, written for civic education.

Source: By PoliticalData.ca

AI-assisted, reviewed before publishing
Short Version

Bill S-232 aims to decriminalize simple illegal substance possession by amending the Controlled Drugs and Substances Act and establishing a national strategy development process.

What It Means

Bill S-232 proposes a national strategy to decriminalize simple possession of illegal substances. It would amend the Controlled Drugs and Substances Act (CDSA) by repealing specific criminal provisions and modifying definitions. The bill also establishes procedures for developing the strategy, including a conference with federal and provincial ministers within 180 days of enactment and a report to Parliament within two years.

What This Bill Does
  • Repeals sections 4 and 4.1 of the Controlled Drugs and Substances Act (CDSA) which criminalize simple possession of certain substances
  • Modifies the definition of 'designated substance offence' to exclude Part I offences except subsection 4(1)
  • Establishes a national strategy development process requiring a conference with federal and provincial ministers within 180 days of enactment
  • Requires a report to Parliament containing the strategy and administrative sanctions regime within two years
  • Amends penalties for substance-related offences, including reduced maximum sentences for certain schedules
  • Creates exemptions from prosecution for individuals seeking emergency medical assistance during a medical emergency involving psychoactive substances
  • Revises time limits for summary conviction proceedings under the CDSA
  • Updates references in Schedules I-IV of the CDSA
  • Makes consequential amendments to the Criminal Code and Proceeds of Crime Act
Who Is Affected
  • Federal and provincial ministers responsible for public health, justice, and safety
  • Individuals seeking emergency medical assistance for substance-related emergencies
  • Persons convicted of substance-related offences
  • Law enforcement agencies
  • Parliament
Uncertainties Or Limits
  • The exact scope of the 'national strategy' and its implementation details are not specified in the text
  • The full implications of Schedule I-IV amendments for specific substances and penalties are not detailed
  • The administrative sanctions regime's structure and application are not described
Laws Or Regulations Affected
Controlled Drugs and Substances Act
amended

Provisions criminalizing simple possession of certain substances would be repealed, and definitions of offences would be modified.

Source: Clauses 4-10

Criminal Code
consequential_amendment

Definitions of designated substance offences and eligibility criteria for registration would be updated.

Source: Paragraph 462.48(1)(a) and section 553

Proceeds of Crime (Money Laundering) and Terrorist Financing Act
consequential_amendment

Eligibility criteria for registration under the Act would be modified.

Source: Subparagraph 11.11(1)(d)(ii)

Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.

Official text

Parliamentary Process

Step 1
First reading
Dec 7, 2021
Completed

Bill S-232, concerning a national strategy for decriminalization of illegal substances, completed its first reading in the Senate on December 7, 2021, and is currently under consideration by a Senate committee.

Introduction and first reading, Dec 7, 2021
End of stage activity, Dec 7, 2021
Chamber sittings
Introduction and first reading - Dec 7, 2021

On December 7, 2021, the Senate held a sitting where Bill S-232 was introduced for first reading, alongside debates on multiple other bills, committee reports, and questions directed to ministers.

Step 2
Second reading
Apr 11, 2024
Completed

Bill S-232's Senate second reading stage was completed on April 11, 2024, advancing the bill to committee review without changing law.

Second reading, Apr 11, 2024
Referral to committee, Apr 11, 2024
End of stage activity, Apr 11, 2024
Chamber sittings
Debate at second reading - Mar 22, 2022

The Senate held a sitting on March 22, 2022, which featured Senators' Statements, Routine Proceedings, Question Period, and Orders of the Day, including debates on various bills and motions related to national strategy for substance use decriminalization, human trafficking, suicide prevention, and municipal-federal relations.

During Senate second reading debate on Bill S-232, Senator Gwen Boniface explained the bill's purpose to create a national strategy for substance use and decriminalize simple possession, emphasizing the need for supports to be in place first and highlighting the widespread impact of the substance use crisis across Canada.

Debate at second reading - May 12, 2022

On May 12, 2022, the Senate held a sitting that included Senators' Statements, Routine Proceedings, Question Period, debate on multiple bills at various stages, delayed answers to oral questions, and committee business.

Debate at second reading - Feb 9, 2023

The Senate sat on February 9, 2023, hearing tributes, holding Question Period with the Minister of Labour, and continuing debate on several bills, including those related to online news, disability benefits, substance use decriminalization, and repealing a section of the Criminal Code.

Debate at second reading - Feb 14, 2023

On February 14, 2023, the Senate held tributes, addressed routine proceedings and questions on various government issues, and continued debates on several bills including those concerning disability benefits, drug decriminalization, and alcohol warning labels.

Debate at second reading - Mar 28, 2023

On March 28, 2023, the Senate held a sitting that included tributes, routine proceedings, question period, and extensive debate on various bills and inquiries, notably featuring an address by U.S. President Joe Biden.

Debate at second reading - Jun 13, 2023

The Senate debate chunk outlines motions related to suicide prevention, resource extraction impacts, and honorary citizenship, with some content incomplete or lacking specific details.

Debate at second reading - Oct 3, 2023

The Senate debate transcripts discuss issues like First Nations rights, digital service improvements, health misinformation, and historical legislation, with each segment containing a title, content, and official source reference.

Debate at second reading - Nov 28, 2023

The Senate debated two bills on November 28, 2023: one addressing agricultural fuel use and climate policy, and the other establishing a national framework for sickle cell disease care and research.

Senators debated Bill C-234's agricultural exemptions and climate implications, while discussing Bill S-280's need for a national sickle cell disease framework, research funding, and newborn screening.

Second reading - Apr 11, 2024

The Senate convened on April 11, 2024, to hold tributes, conduct routine proceedings, address questions on various national issues, and debate and advance several bills, including Bill S-232 which was referred to committee.

Step 3
Consideration in committee
Date not listed
No activity

Bill S-232 is currently undergoing committee review in the Senate with no reported activity in that stage, following its referral on April 11, 2024.

Step 4
Report stage
Not reached yet
Not reached

Bill S-232 is currently at the 'Senate Report stage', which has not yet been reached, following referral to committee and prior readings and speeches.

Step 5
Third reading
Not reached yet
Not reached

Bill S-232 is currently under committee review in the Senate and has not yet reached the third reading stage.

Step 1
First reading
Not reached yet
Not reached

This record details the 'House of Commons First reading' stage for Bill S-232, noting it has not yet been reached and the bill is currently under Senate committee consideration.

Step 2
Second reading
Not reached yet
Not reached

The House of Commons Second Reading stage for Bill S-232 has not yet occurred, and the bill is currently under consideration in a Senate committee.

Step 3
Consideration in committee
Not reached yet
Not reached

Bill S-232 has reached the 'Consideration in committee' stage in the House of Commons, though this stage has not yet taken place, with prior readings and speeches documented.

Step 4
Report stage
Not reached yet
Not reached

Bill S-232 has not yet reached the Report stage in the House of Commons and is currently under consideration in a Senate committee.

Step 5
Third reading
Not reached yet
Not reached

Bill S-232, an Act respecting the development of a national strategy for the decriminalization of illegal substances, has reached the 'House of Commons Third reading' stage, which has not yet occurred, and is currently under consideration in a Senate committee.

Debate and sitting links point to official parliamentary sources when LEGISinfo publishes them. Any plain-language discussion summaries should be generated from those official texts and reviewed before public display.

Vote Summary

No published recorded division

This bill is still active. We only show vote counts after the legislature publishes a recorded division.

Sponsor
Gwen Boniface
Senator | Details not listed in current Senate roster
Jurisdiction
Federal Parliament

No published representative vote breakdown

This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.

Official sources

Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.

How this data is sourced